Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy

Completed · Phase 2

Conditions studied: Ovarian Cancer, Primary Peritoneal Cavity Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of oxaliplatin in treating patients who have recurrent or refractory ovarian epithelial cancer or primary peritoneal cancer that has not responded to platinum-based chemotherapy.

Key facts

Study ID

NCT00005836

Run by

Gynecologic Oncology Group

Starts

2000-02-01

Expected to finish

2004-07-01

Last updated by the study team

2013-06-21

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

Where it is running

• CCOP - Greater Phoenix — Phoenix, Arizona, United States
• USC/Norris Comprehensive Cancer Center — Los Angeles, California, United States
• Jonsson Comprehensive Cancer Center, UCLA — Los Angeles, California, United States
• Chao Family Comprehensive Cancer Center — Orange, California, United States
• Women's Cancer Center — Palo Alto, California, United States
• University of Colorado Cancer Center — Denver, Colorado, United States
• Vincent T. Lombardi Cancer Research Center, Georgetown University — Washington D.C., District of Columbia, United States
• Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States
• H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
• Emory University Hospital - Atlanta — Atlanta, Georgia, United States
• MBCCOP - Hawaii — Honolulu, Hawaii, United States
• MBCCOP - University of Illinois at Chicago — Chicago, Illinois, United States
• Rush-Presbyterian-St. Luke's Medical Center — Chicago, Illinois, United States
• University of Chicago Cancer Research Center — Chicago, Illinois, United States
• CCOP - Evanston — Evanston, Illinois, United States
• CCOP - Central Illinois — Springfield, Illinois, United States
• Indiana University Cancer Center — Indianapolis, Indiana, United States
• CCOP - Iowa Oncology Research Association — Des Moines, Iowa, United States
• University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
• Albert B. Chandler Medical Center, University of Kentucky — Lexington, Kentucky, United States
• Johns Hopkins Oncology Center — Baltimore, Maryland, United States
• Medicine Branch — Bethesda, Maryland, United States
• Radiation Oncology Branch — Bethesda, Maryland, United States
• Tufts University School of Medicine — Boston, Massachusetts, United States
• University of Alabama Comprehensive Cancer Center — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.